Nanoencapsulation of blocked isocyanates through aqueous emulsion polymerization by unknown
1. Introduction
The synthesis and application of nanoparticles, i.e.,
particles smaller than one micron, are of growing
interest to both industry and academia. Nanocap-
sules, a specific class of nanoparticles, are com-
posed of one or more active materials (core) and a
protective matrix (shell) [1]. Encapsulation tech-
nology has been used to prepare micro/nanocap-
sules with specific application properties in several
areas including food [2], biology [3], and medicine
[4]. Nanocapsules have been synthesized via
miniemulsion [5, 6] and interfacial polymerization
[7, 8] techniques. Couvreur reviewed nanocapsule
technologies used in drug carrier systems [9].
Most encapsulation techniques employ isocyanates
in either solvent or bulk to form shell (or matrix)
materials for encapsulating functional materials,
releasable fill materials [10], or making pressure
sensitive copying paper [11]. The inherent reactiv-
ity of isocyanates with water makes it difficult to
encapsulate them in aqueous media. It is even more
challenging to maintain isocyanate activity in the
presence of hydroxyl- or amine-functional systems.
There are no references found in literature for either
the incorporation of blocked isocyanates into poly-
meric nanoparticles or the encapsulation of iso-
cyanates into reactive polymeric shell materials in
aqueous media.
In this study, blocked isocyanates were encapsu-
lated within polystyrene nanocapsules and in
hydroxyl and amine functionalized nanocapsules
via emulsion polymerization. Upon thermal treat-
ment, the blocking agent was released and active
isocyanate functionalities were generated that
remained stable in the aqueous medium within the
protective shell of the nanocapsules. The nanocap-
sules were characterized via Fourier transform
infrared (FTIR) spectroscopy, differential scanning
calorimetry (DSC), and transmission electron
microscopy (TEM).
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2.1. Materials
Desmodur® N 3300A and Desmodur BL 3175A
were received from Bayer MaterialScience, Pitts-
burgh, PA. 2-Hydroxyethyl methacrylate (HEMA),
divinylbenzene (DVB), 2-(tert-butylamino)ethyl
methacrylate (TBAEMA), 2,2′-azobisisobutyroni-
trile (AIBN), and sodium dodecyl sulfate (SDS)
were purchased from Sigma-Aldrich, St. Louis,
MO. Styrene was purchased from Alfa Aesar,
Ward Hill, MA. Igepal® CO-887 was received from
Rhodia, Cranbury, NJ. All reagents were used as
received.
2.2. Preparation of nanocapsules
The nanocapsules were prepared through two steps
of pre-emulsification (to form a pre-emulsion) and
emulsion polymerization, which will be explained
in detail below.
2.2.1. Pre-emulsion preparation
Pre-emulsion preparation for one of the nanocap-
sules (M-6) is provided as an example. The pre-
emulsion was synthesized by blending two parts;
Part I contained 40 g styrene, 0.8 g DVB, 0.82 g
AIBN, and 40 g Desmodur BL3175A; and Part II
contained 1.71 g SDS, 1.63 g Igepal CO-887, and
220 g water. Parts I and II were blended magneti-
cally in separate containers for 10 minutes. Part II
was then added to Part I under mechanical agitation
and the contents were stirred for 30 minutes at
1800 rpm. The resulting pre-emulsion was cooled
to <5°C before sonication using a Misonix® sonica-
tor 3000 (until a particle size <250 nm was
achieved).
2.2.2. Emulsion polymerization
The pre-emulsion was transferred to a three-neck
round bottom flask equipped with a mechanical
stirrer, reflux condenser, and a nitrogen inlet, and
degassed for 30 minutes. The temperature was
raised to 70°C and maintained for 8 hours to com-
plete the polymerization.
2.3. Characterization
The latexes were freeze dried (lyophilization) for
48 hours in the Freezemobile 35EL. Glass transi-
tion temperatures (Tgs) were recorded on a differ-
ential scanning calorimeter (DSC Q1000, TA
Instruments,  New Castle, DE), summarized in
Table 1. FTIR spectroscopy (attenuated total
reflectance and diffuse reflectance, unless specifi-
cally stated) was performed using a Scimitar series
spectrophotometer (Digilab, Canton, MA). Latex
particle sizes were recorded on a capillary hydrody-
namic fractionator (CHDF 2000, Matec Applied
Sciences, Northborough, MA). TEM was per-
formed on a JEOL JEM-2100 microscope (JEOL
Ltd., Tokyo, Japan).
For deblocking studies, the freeze dried samples
were treated thermally in the DSC under a nitrogen
atmosphere as summarized in Table 2 and charac-
terized via FTIR.
For acetone extraction studies, the freeze dried
samples were blended with acetone and agitated on
a Vortex-Genie 2TM shaker for 48 hours. The blend
was centrifuged using SPD SpeedVac® SPD 121P
(Thermo Fisher Scientific, Waltham, MA), and the
supernatant liquid was discarded (repeated twice,
20 minutes centrifugation). The pellets were air
dried for further analysis.
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Table 1. DSC Measurement procedure
Table 2. Deblocking treatment procedure
Step
Equilibrate
[°C]
Ramp to
(at 10°C/min)
[°C]
Isothermal
[min]
I –50 – –
II (1st heating) – 120 3
III – –50 3
IV (2nd heating) – 180 3
V – –50 3
VI (3rd heating) – 180 3
VII – –50 3
VIII (4th heating) – 180 –
Step
Equilibrate
[°C]
Ramp to
(at 10°C/min)
[°C]
Isothermal
[min]
I –50 – –
II – 120 1
III – –50 3
IV – 160 40
V – –50 3
VI – 180 –3. Results and discussion
3.1. Isocyanate encapsulated by polystyrene
Blocked isocyanates (BNCO) are widely used in
coatings, elastomers, composites, and rubber indus-
tries to thermally regenerate isocyanate functionali-
ties. In this study, Desmodur BL3175A, a blocked
aliphatic polyisocyanate based on hexamethylene
diisocyanate (75% solids, deblocking temperature
~135°C) was chosen for encapsulation into nano-
capsules. The BNCO nanocapsules prepared via
miniemulsion polymerization are summarized in
Tables 3 and 4 (non-functionalized and functional-
ized nanocapsules are designated as M and N
series, respectively). Desmodur N3300A (poly-
meric hexamethylene diisocyanate) was employed
as the control for FTIR characterization. The latex
particle sizes are included in the tables and were
also confirmed by TEM (TEM image of nanocap-
sule M-7 is shown as an example in Figure 1).
3.1.1. FTIR analysis
Isocyanates are characterized by peaks at 1682
(urethane C=O stretching) and 2270 cm–1 (N=C=O
stretching) for Desmodur N3300A, and at 1682
(urethane C=O stretching) and 1725 cm–1 (blocked
isocyanate >C=N–O–C(O)–NH, C=O stretching)
for Desmodur BL3175A (Figures 2a and 2b). The
presence of the characteristic BNCO peaks in the
FTIR spectrum of the nanocapsule, M-6 (Fig-
ure 2e), and its absence in the FTIR spectrum of the
hollow nanosphere, M-1 (Figure 2d), confirmed
BNCO inclusion in the nanocapsules.
Nanocapsule M-6 was treated with acetone to
extract the incorporated BNCO. The FTIR spec-
trum of M-6 after acetone extraction (Figure 2f)
shows complete disappearance of the characteristic
BNCO peaks indicating that the blocked isocyanate
was extracted from the nanocapsules by acetone.
Nanocapsules containing the blocked isocyanates
generated active isocyanates upon thermal treat-
ment. For deblocking studies, the nanocapsules
were freeze dried and treated thermally in the DSC
to release the blocking agent. The FTIR spectrum
of the BNCO nanocapsule M-6 subjected to
deblocking treatment shows the characteristic iso-
cyanate peak (2270 cm–1) (Figure 2g). Figure 2c
displays the effect of the deblocking thermal treat-
ment on the blocked isocyanate BL3175A. While
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Table 3. Blocked isocyanate (BNCO) nanocapsules
*weight percentage on styrene
Sample DVB* [%] BNCO* [%] Particle size [nm]
M-1 2 0 58
M-2 2 10 59
M-3 0 10 57
M-4 2 20 59
M-5 2 30 62
M-6 2 40 59
M-7 2 60 53
M-8 2 80 82
M-9 0 30 56
M-10 4 30 53
M-11 6 30 57
Figure 1. TEM photo of M-7 (scale bar is 100 nm)
Figure 2. FTIR spectra of a) N3300A, b) BL3175A,
c) BL3175A after deblocking treatment, d) M-1,
e) M-6, f) M-6 after acetone extraction, and
g) M-6 after deblocking treatmentthe presence of the isocyanate peak at 2270 cm–1
indicates deblocking, the peak at 1725 cm–1 indi-
cates that the BNCO was not completely deblocked
by the thermal treatment. The deblocking appeared
to be a function of time, therefore BL3175A and
nanocapsule M-7 (2% DVB, 60% BNCO) were
heated isothermally at 140°C for varying lengths of
time and analyzed via FTIR (Figures 3 and 4).
In Figure 3a, the first curve for BL3175A (0 min,
bottom line) reveals a small amount of deblocked
NCO, which indicates initiation of the deblocking
process at 140°C. Subsequent spectra show the
effects of isothermal heating of BL3175A for vary-
ing lengths of time. The close-up profile (Figure 3a,
area A) shows increasing intensity of the NCO
peak (2270 cm–1) with time. Even after 70 minutes
at 140°C (top line), a small peak is visible at
1725 cm–1 (peak B) suggesting the presence of
residual blocked isocyanate. Since the ATR method
primarily probes only the top two microns of the
sample that is in direct contact with the ZnSe crys-
tal, the deblocking of BL3175A was also analyzed
via transmission FTIR on sodium chloride plates
(Figure 3b). To show the time-dependent deblock-
ing property of BNCO, the transmission FTIR data
were re-plotted after normalization at 1682 cm–1. It
is evident that the peak A height increased while
peak B decreased with time. Peak B disappeared
after 50 minutes at 140°C, suggesting that by this
time, the isocyanate is completely dissociated via
thermal treatment of blocked isocyanate.
A similar heating profile for the M-7 BNCO nano-
capsule summarizes the effect of deblocking by the
appearance and continued presence of deblocked
isocyanate (Figure 4). At the end of 120 minutes,
the 1725 cm–1 peak has almost disappeared indicat-
ing complete deblocking of the original BNCO and
free NCO retention.
3.1.2. Effects of crosslinking
The blocking and deblocking of diisocyanates with
methyl ethyl ketoxime is a reversible reaction [12].
In these nanocapsules, the polystyrene shell func-
tions as a ‘shield’ for the deblocked isocyanate by
preventing the liberated blocking agent from re-
entering the nanocapsule. As shown in Figure 5,
varying the degree of crosslinking in the poly-
styrene shell further exemplifies the ‘shield effect’
(FTIR spectra of N3300A, BL3175A, and BL3175A
after deblocking treatment are re-plotted to facili-
tate comparison).
After subjecting the nanocapsule M-9 (no DVB
crosslinker in the shell) to the deblocking treat-
ment, a small shoulder peak is revealed at
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Figure 3. FTIR spectra of BL3175A maintained isother-
mally for various times at 140°C with a) ATR
and b) transmission methods
Figure 4. FTIR spectra of M-7 maintained isothermally
for various times at 140°C1725 cm–1, indicating the presence of residual
BNCO (Figure 5f). Nanosphere M-1 (no blocked
isocyanate) was blended with BL3175A in the
same proportion as present in nanocapsule M-6 and
subjected to deblocking treatment (Figure 5e). The
strong peak at 1725 cm–1 observed upon deblock-
ing the blend indicates the effect of the polystyrene
shell on the reaction between the isocyanate and the
liberated blocking agent. Increasing the proportion
of DVB from 2% (M-5) to 6% (M-11) results in
shorter peaks at 1725 cm–1 (Figures 5h and 5i). The
data validate that increasing the shell’s degree of
crosslinking (polystyrene shell) enhances the
‘shield effect’.
3.1.3. DSC analysis
DSC thermograms of lyophilized nanocapsules are
summarized in Figure 6. BL3175A (Figure 6a)
exhibits a Tg of –11.26°C in the second heating
cycle before the isocyanate deblocks at 136.59°C.
The Tg shifted to –2.51°C in the next heating cycle
and the deblocking peaks were no longer evident.
However, this does not signify complete deblock-
ing of the blocked isocyanate. For instance, the
DSC profile of the thermally treated BL3175A
(Figure 2c), does not exhibit a deblocking thermal
peak in the heating cycle following isothermal
treatment at 160°C for 40 minutes but the IR spec-
trum of the same sample shows the presence of
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Figure 5. FTIR spectra of a) N 3300A, b) BL3175A,
c) BL3175A after deblocking treatment, d) M-1,
e) M-1 and BL3175A blend after deblocking
treatment, f) M-9 after deblocking treatment,
g) M-5 after deblocking treatment, h) M-10 after
deblocking treatment, and i) M-11 after deblock-
ing treatment
Figure 6. DSC profiles of Desmodur BL3175A and nanocapsulesresidual blocked isocyanates. Two distinct Tgs are
discernible in the DSC profile of nanocapsule M-7
(Figure 6b). The first Tg of approximately –5°C is
attributed to the incorporated BNCO, and the sec-
ond Tg of approximately 105°C is attributed to the
presence of partially crosslinked polystyrene. The
separate and distinct Tgs confirm distinct phase sep-
aration within nanocapsules.
The effects of time and temperature on deblocking
BL3175A should also be noticed in the DSC ther-
mograms of nanocapsules containing varying
amounts of BNCO. Nanocapsules containing >20%
BNCO exhibited exothermic responses after the
second heating cycle, while nanocapsules contain-
ing <20% BNCO did not show similar responses
(the profile is not included in Figure 6). Addition-
ally, higher degrees of crosslinking in the shell
(DVB increased from 2 to 6 wt%) also required
longer deblocking times (Figure 6d). Higher
crosslinking of the shell is seen to promote the
‘shield effect’. DSC analysis was also conducted
with open samples (no lid) and closed samples (pan
capped with a small hole in the center). The DSC
thermograms shown in this paper were all recorded
on closed pans. The thermal behaviors of both
processes were similar except for the lack of
exothermic responses in the open samples, which
reflect the effect of crosslinking on the deblocking
behavior and the reversible nature of blocked iso-
cyanates establishing an equilibrium in sealed pans,
which is consistent with the observations reported
by Wicks [13].
3.2. Hydroxyl or amine functionalized
polymers encapsulated isocyanate
nanocapsule
The above synthesis technique was repeated using
HEMA and TBAEMA as comonomers with
styrene and divinyl benzene to encapsulate iso-
cyanates via miniemulsion polymerization. The
resulting N-series of nanocapsules are summarized
in Table 4.
3.2.1. Encapsulation of isocyanate by hydroxyl
functionalized polymer
Isocyanate encapsulation was confirmed via FTIR
characterization. The FTIR spectra of N3300A and
BL3175A are re-plotted for comparison in Fig-
ures 7 and 8. The nanocapsule N-5 (Figure 7e)
shows a characteristic BNCO peak at 1682 cm–1
that is not observed in the FTIR spectrum of the
empty nanosphere, N-4 (Figure 7d), and confirms
the presence of blocked isocyanate. However, the
peak at 1725 cm–1 overlaps with the HEMA ester
carbonyl of N-4.
The IR spectrum of N-5 treated with acetone to
extract the encapsulated BNCO (Figure 7f) shows
total disappearance of the BNCO peak at
1682 cm–1 confirming blocked isocyanate extrac-
tion from the nanocapsules by acetone. The data
also suggests that a core-shell structure (isocyanate
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Figure 7. FTIR spectra of a) N3300A, b) BL3175A,
c) BL3175A after deblocking treatment, d) N-4,
e) N-5, f) N-5 after acetone extraction, g) blend
of N-4 and BL3175A after deblocking treat-
ment, h) N-5 after deblocking treatment, and i)
N-6 after deblocking treatment
Table 4. Hydroxyl or amine functionalized BNCO nanocapsules
*weight percentage on total monomer
Sample DVB* [%] BNCO* [%]
HEMA/S
weight ratio
TBAEMA/S
weight ratio
Particle size
[nm]
N-4 2 0 0.25 – 61
N-5 2 30 0.25 – 57
N-6 0 30 0.25 – –
N-7 2 30 – 0.25 62
N-8 2 0 – 0.25 –
N-9 0 30 – 0.25 –core) for nanocapsules was maintained until ace-
tone extraction.
For isocyanate releasing studies, nanocapsules N-6
were freeze dried and treated thermally in the DSC
to release the blocking agent. Figures 7c, 7g, and
7h show the effects of deblocking treatment on
BL3175A, blend of nanospheres N-4 and BL3175A,
and N-5, respectively. While the presence of the
free NCO peak at 2270 cm–1 indicates deblocking
of BL3175A, the peak at 1725 cm–1 supports the
presence of residual BNCO. After the deblocking
treatment, nanocapsule N-5 showed the characteris-
tic NCO peak at 2270 cm–1 indicating the presence
of active isocyanate functional groups. The func-
tionalized nanocapsules are expected to have the
hydroxyl groups on the outside of the shell due to
their hydrophilicity. When the blend of hydroxyl-
functional empty nanosphere N-4 and BL3175A
was subjected to the deblocking treatment (Fig-
ure 7g), no peak was seen at 2270 cm–1 suggesting
that the isocyanate generated upon deblocking had
reacted with the hydroxyl groups present on the
nanosphere. On the other hand, the isocyanate gen-
erated upon deblocking in nanocapsule N-5 is
retained in the core of the nanocapsule and does not
react with the hydroxyl groups on the outside of the
shell. The data is strong support for the efficient
encapsulation of isocyanate by the hydroxyl func-
tionalized polymer shells.
The degree of crosslinking in the shell is also
demonstrated in Figure 7. Unlike nanocapsule N-5
(2% DVB in the shell), the nanocapsule N-6 (no
crosslinker in the shell) does not display the NCO
peak at 2270 cm–1 after deblocking thermal treat-
ment (Figure 7i). During deblocking, the active iso-
cyanate flows from the uncrosslinked shell, and
reacts with the hydroxyl groups on the outside of
the shell. It is obvious therefore that DVB plays an
important role as a crosslinker in confining the
BNCO to the core of the nanocapsule.
3.2.2. Encapsulation of isocyanate by amine
functionalized polymer
The nanocapsule N-7 (Figure 8e) shows a charac-
teristic BNCO peak at 1682 cm–1 that is not
observed in the FTIR spectrum of the empty nanos-
phere N-8 (Figure 8d). The peak at 1725 cm–1 over-
laps with the TBAEMA ester carbonyl of N-8.
The IR spectrum of N-7 treated with acetone to
extract the encapsulated BNCO (Figure 8f) shows
the total disappearance of the BNCO peak at
1682 cm–1 indicating that the blocked isocyanate
was extracted from the nanocapsules by acetone,
and supports the core (isocyanate)-shell structure of
the nanocapsules. Figures 8c, 8g, and 8h summa-
rize the effect of deblocking treatment on BL3175A,
blend of nanospheres N-8 and BL3175A, and N-7,
respectively. After deblocking, nanocapsule N-7
exhibits the characteristic NCO peak at 2270 cm–1
indicating the presence of active isocyanate func-
tional groups. This peak is not seen in the similarly
treated blend of empty nanospheres N-8 and
BL3175A (Figure 8g) as the active isocyanate gen-
erated upon deblocking reacts with the TBAEMA
amine groups present on the nanocapsule shell.
However, the isocyanate generated upon deblock-
ing in nanocapsule N-7 does not react with amine
groups, and remains in the core as the dissociated
free isocyanate, thus confirming the isocyanate
encapsulation.
The nanocapsule N-9 (Figure 8i) without DVB
crosslinker in the shell does not depict a NCO peak
at 2270 cm–1 after deblocking treatment. As dis-
cussed earlier, it is believed that the deblocked iso-
cyanate is able to flow from the uncrosslinked shell
and react with the amine groups on the shell periph-
ery.
Since isocyanate deblocking appeared to be a func-
tion of time, nanocapsule N-7 was heated isother-
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Figure 8. FTIR spectra of a) N3300A, b) BL3175A,
c) BL3175A after deblocking treatment, d) N-8,
e) N-7, f) N-7 after acetone extraction, g) blend
of N-8 and BL3175A after deblocking treat-
ment, h) N-7 after deblocking treatment, and
i) N-9 after deblocking treatmentmally at 140°C for varying lengths of time (Fig-
ure 9). The characteristic BNCO peak at 1725 cm–1
decreased steadily with time. At 170 minutes, a
small shoulder is seen that represents the TBAEMA
ester carbonyl. The time-dependent deblocking
behavior noted here is consistent with our earlier
observations. The NCO peak at 2270 cm–1 con-
firms that the deblocked isocyanates were retained
in the core of the nanocapsule and not consumed by
the amine groups on the nanocapsule periphery.
4. Conclusions
Isocyanates have been successfully encapsulated
into polystyrene, and hydroxyl and amine function-
alized nanospheres using a commercially available
blocked isocyanate. The research provides a new
method for synthesizing nanocapsules containing
either blocked or free isocyanates in aqueous
media. The thermally dissociated isocyanate can be
utilized as an active functional group in coatings
and adhesive applications. Nanocapsules contain-
ing blocked isocyanates are of interest in self-heal-
ing systems where the isocyanate can be liberated
by thermal treatment or extracted via solvent or
reactive agents such as amines. Nanocapsule shells
functionalized with amines and hydroxyls provide
a ready moiety for the isocyanate to react once it is
liberated from the protective shell of the nanocap-
sule. Quantitative characterization of the encapsu-
lated isocyanate and the reactivity of released
isocyanate are under investigation and will be
reported in a subsequent article.
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Figure 9. FTIR spectra of N-7 maintained isothermally
at 140°C